News|Articles|October 15, 2020
- Pharmaceutical Technology-10-15-2020
- Volume 2020 eBook
- Issue 3
Ending ‘Magical Thinking’ in Compounding
Author(s)Agnes Shanley
Consistent product quality requires a clear understanding of the essence of CGMPs. Experts fear that the message is not always getting through to compounders.
Advertisement
Pharmaceutical compounding recalls the earliest days of medicine making, when the mortar and pestle, and variability, were the rule. Since that time, and the establishment of the United States Pharmacopeia (USP) and FDA in the United States, the field has come a long way.
Article Details
Pharmaceutical Technology
eBook: Regulatory Sourcebook
October 2020
Pages: 46-51
Citation
When referring to this article, please cite it as A. Shanley, “Ending ‘Magical Thinking’ in Compounding," Pharmaceutical Technology Regulatory Sourcebook eBook (October 2020).
Articles in this issue
about 5 years ago
Enhancing Process Validation for Solid Oral Dosage Forms: Part 2about 5 years ago
Due Diligence Assessment of CMC Activitiesabout 5 years ago
Tackling Cybersecurity Challenges in Legacy Systemsabout 5 years ago
Viral Vector API Characterization of Product-Related Impuritiesabout 5 years ago
Strong Quality Culture: A How-To for Busy Managersabout 5 years ago
Resources, Guidelines, and Guidance Documentsabout 5 years ago
Regulatory and Standard Setting OrganizationsNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
